Chi-Jene Chen

Chi-Jene Chen

Auto-generated profile, based on publicly available information

Chi-Jene Chen

Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Emerging Infectious Diseases
Verified
Journal Article
Open access
GCGuang-Wu Chen
Guang-Wu Chen
SCShih-Cheng Chang
Shih-Cheng Chang
Chee Keng MOKChee Keng MOK
Chee Keng MOK
YLYu-Luan Lo
Yu-Luan Lo
YKYu-Nong Kung
Yu-Nong Kung
SSShin-Ru Shih
Shin-Ru Shih
Position-specific entropy profiles created from scanning 306 human and 95 avian influenza A viral genomes showed that 228 of 4,591 amino acid residues yielded significant differences between these 2 viruses. We subsequently used 15,785 protein sequences from the National Center for Biotechnology Information (NCBI) to assess the robustness of these signatures and obtained 52 "species-associated" positions. Specific mutations on those points may enable an avian influenza virus to become a human virus. Many of these signatures are found in NP, PA, and PB2 genes (viral ribonucleoproteins [RNPs]) and are mostly located in the functional domains related to RNP-RNP interactions that are important for viral replication. Upon inspecting 21 human-isolated avian influenza viral genomes from NCBI, we found 19 that exhibited >1 species-associated residue changes; 7 of them contained >2 substitutions. Histograms based on pairwise sequence comparison showed that NP disjointed most between human and avian influenza viruses, followed by PA and PB2.

1 July 2017 in Trends in Microbiology
Verified
Journal Article
Closed access
KLKuo-Ming Lee
Kuo-Ming Lee
CCChi-Jene Chen
Chi-Jene Chen
SSShin-Ru Shih
Shin-Ru Shih

10 October 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
WHWenqian He
Wenqian He
CCChi-Jene Chen
Chi-Jene Chen
CMCaitlin E. Mullarkey
Caitlin E. Mullarkey
JHJennifer R. Hamilton
Jennifer R. Hamilton
CWChristine K. Wong
Christine K. Wong
GTGene S. Tan
Gene S. Tan
The aim of candidate universal influenza vaccines is to provide broad protection against influenza A and B viruses. Studies have demonstrated that broadly reactive antibodies require Fc–Fc gamma receptor interactions for optimal protection; however, the innate effector cells responsible for mediating this protection remain largely unknown. Here, we examine the roles of alveolar macrophages, natural killer cells, and neutrophils in antibody-mediated protection. We demonstrate that alveolar macrophages play a dominant role in conferring protection provided by both broadly neutralizing and non-neutralizing antibodies in mice. Our data also reveal the potential mechanisms by which alveolar macrophages mediate protection in vivo, namely antibody-induced inflammation and antibody-dependent cellular phagocytosis. This study highlights the importance of innate effector cells in establishing a broad-spectrum antiviral state, as well as providing a better understanding of how multiple arms of the immune system cooperate to achieve an optimal antiviral response following influenza virus infection or immunization.

21 January 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JYJiann-Yih Yeh
Jiann-Yih Yeh
MCMohane Coumar
Mohane Coumar
JHJim-Tong Horng
Jim-Tong Horng
HSHui-Yi Shiao
Hui-Yi Shiao
FKFu-Ming Kuo
Fu-Ming Kuo
HHHsing-Pang Hsieh
Hsing-Pang Hsieh

1 October 2010 in Journal of Virology
Verified
Journal Article
Closed access
CCChi-Jene Chen
Chi-Jene Chen
GCGuang-Wu Chen
Guang-Wu Chen
CWChing-Ho Wang
Ching-Ho Wang
CHChih-Heng Huang
Chih-Heng Huang
YWYeau-Ching Wang
Yeau-Ching Wang
SSShin-Ru Shih
Shin-Ru Shih
PB1-F2 is a viral protein that is encoded by the PB1 gene of influenza A virus by alternative translation. It varies in length and sequence context among different strains. The present study examines the functions of PB1-F2 proteins derived from various human and avian viruses. While H1N1 PB1-F2 was found to target mitochondria and enhance apoptosis, H5N1 PB1-F2, surprisingly, did not localize specifically to mitochondria and displayed no ability to enhance apoptosis. Introducing Leu into positions 69 (Q69L) and 75 (H75L) in the C terminus of H5N1 PB1-F2 drove 40.7% of the protein to localize to mitochondria compared with the level of mitochondrial localization of wild-type H5N1 PB1-F2, suggesting that a Leu-rich sequence in the C terminus is important for targeting of mitochondria. However, H5N1 PB1-F2 contributes to viral RNP activity, which is responsible for viral RNA replication. Lastly, although the swine-origin influenza virus (S-OIV) contained a truncated form of PB1-F2 (12 amino acids [aa]), potential mutation in the future may enable it to contain a full-length product. Therefore, the functions of this putative S-OIV PB1-F2 (87 aa) were also investigated. Although this PB1-F2 from the mutated S-OIV shares only 54% amino acid sequence identity with that of seasonal H1N1 virus, it also increased viral RNP activity. The plaque size and growth curve of the viruses with and without S-OIV PB1-F2 differed greatly. The PB1-F2 protein has various lengths, amino acid sequences, cellular localizations, and functions in different strains, which result in strain-specific pathogenicity. Such genetic and functional diversities make it flexible and adaptable in maintaining the optimal replication efficiency and virulence for various strains of influenza A virus.

1 December 2017 in Microbes and Infection
Verified
Journal Article
Closed access
CCChi-Jene Chen
Chi-Jene Chen
GWGuan-Hong Wu
Guan-Hong Wu
RKRei-Lin Kuo
Rei-Lin Kuo
SSShin-Ru Shih
Shin-Ru Shih